FilingReader Intelligence

Santen Pharmaceutical repurchases $47m shares in buyback program

August 1, 2025 at 12:09 PM UTCBy FilingReader AI

Santen Pharmaceutical repurchased 4.2 million shares for JPY 7.0 billion in July as part of its larger buyback program.

The company has now repurchased 8.6 million shares totaling JPY 14.1 billion under the program approved in May, which authorizes buying up to 19.8 million shares for a maximum JPY 35.0 billion through November.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Santen Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →